» Articles » PMID: 26545730

Serum Caspase-3 Levels and Mortality Are Associated in Patients with Severe Traumatic Brain Injury

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2015 Nov 8
PMID 26545730
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Different apoptosis pathways activate caspase-3. In a study involving 27 patients with traumatic brain injury (TBI), higher caspase-3 levels were found in contusion brain tissue resected from non-survivors than from survivors. The objective of this study was to determine whether there is an association in TBI patients between serum caspase-3 levels (thus using an easier, quicker, less expensive and less invasive procedure) and mortality, in a larger series of patients.

Methods: We carried out a prospective, observational and multicenter study in six Spanish Hospital Intensive Care Units including 112 patients with severe TBI. All had Glasgow Coma Scale (GCS) scores lower than 9. Patients with an Injury Severity Score (ISS) in non-cranial aspects higher than 9 were excluded. Blood samples were collected on day 1 of TBI to measure serum caspas-3 levels. The endpoint was 30-day mortality.

Results: We found that non-surviving patients (n = 31) showed higher (p = 0.003) serum caspase-3 levels compared to survivors (n = 81). Kaplan-Meier survival analysis showed a higher risk of death in TBI patients with serum caspase-3 levels >0.20 ng/mL than in patients with lower concentrations (Hazard Ratio = 3.15; 95% CI = 1.40 to 7.08; P < 0.001). Multiple logistic regression analysis showed that serum caspase-3 levels > 0.20 ng/mL were associated with mortality at 30 days in TBI patients controlling for Marshall CT classification, age and GCS (Odds ratio = 7.99; 95% CI = 2.116 to 36.744; P = 0.001).

Conclusions: The association between serum caspase-3 levels and mortality in TBI patients was the major novel finding of our study.

Citing Articles

Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats.

Klein B, Ciesielska A, Losada P, Sato A, Shah-Morales S, Ford J Mol Ther. 2024; 33(1):375-400.

PMID: 39668560 PMC: 11764858. DOI: 10.1016/j.ymthe.2024.12.006.


Plasma neurological biomarkers as a measure of neurotoxicity in pediatric dental general anesthesia: a prospective observational feasibility study.

Chakithandy S, Nazzal H, Matoug-Elwerfelli M, Narasimhan S, Uddin S, Prabhu K Eur Arch Paediatr Dent. 2024; 25(2):267-275.

PMID: 38649631 PMC: 11058848. DOI: 10.1007/s40368-024-00884-9.


Evaluation of cholinergic enzymes and selected biochemical parameters in the serum of patients with a diagnosis of acute subarachnoid hemorrhage.

Aycan A, Tas A, Cilingir Yeltekin A, El-Tekreti S, Arslan A, Arslan M Transl Neurosci. 2023; 14(1):20220311.

PMID: 37873057 PMC: 10590606. DOI: 10.1515/tnsci-2022-0311.


The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders.

Prajapati A, Mehan S, Khan Z Biogerontology. 2023; 24(4):493-531.

PMID: 37097427 DOI: 10.1007/s10522-023-10034-1.


YTHDF1 Attenuates TBI-Induced Brain-Gut Axis Dysfunction in Mice.

Huang P, Liu M, Zhang J, Zhong X, Zhong C Int J Mol Sci. 2023; 24(4).

PMID: 36835655 PMC: 9966860. DOI: 10.3390/ijms24044240.


References
1.
Eberspacher E, Heimann K, Hollweck R, Werner C, Schneider G, Engelhard K . The effect of electroencephalogram-targeted high- and low-dose propofol infusion on histopathological damage after traumatic brain injury in the rat. Anesth Analg. 2006; 103(6):1527-33. DOI: 10.1213/01.ane.0000247803.30582.2d. View

2.
Shah S, Prough D, Garcia J, DeWitt D, Hellmich H . Molecular correlates of age-specific responses to traumatic brain injury in mice. Exp Gerontol. 2006; 41(11):1201-5. DOI: 10.1016/j.exger.2006.07.006. View

3.
Abrahamson E, Ikonomovic M, Ciallella J, Hope C, Paljug W, Isanski B . Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome. Exp Neurol. 2005; 197(2):437-50. DOI: 10.1016/j.expneurol.2005.10.011. View

4.
Soustiel J, Palzur E, Nevo O, Thaler I, Vlodavsky E . Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J Neurotrauma. 2005; 22(3):345-52. DOI: 10.1089/neu.2005.22.345. View

5.
Clark R, Kochanek P, Chen M, Watkins S, Marion D, Chen J . Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. 1999; 13(8):813-21. DOI: 10.1096/fasebj.13.8.813. View